Research Trends and Development Dynamics of QPCR-based Biomarkers: A Comprehensive Bibliometric Analysis

Overview

Journal Mol Biotechnol

Publisher Springer

Date 2025 Jan 22

PMID 39843617

Authors

Li Liu

Ben-Rong Mu

Ya Zhou

Qing-Lin Wu

Bin Li

Dong-Mei Wang

Mei-Hong Lu

Affiliations

Soon will be listed here.

Abstract

Quantitative polymerase chain reaction (qPCR) is a vital molecular technique for biomarker detection; however, its clinical application is impeded by the scarcity of robust biomarkers and the inherent limitations of the technology. This study conducted a bibliometric analysis of 4063 qPCR-based biomarker studies sourced from the Web of Science (WOS) database, employing VOSviewer and CiteSpace to generate multi-dimensional structural insights into this field. The results reveal a growing trend in research within this domain, with gene expression analysis playing a central role in the identification of potential biomarkers. Among these, cancer-related biomarkers are the most prominent, while research on biomarkers for other diseases remains limited. Liquid biopsy biomarkers, including microRNA (miRNA), circulating free DNA (cfDNA), and circulating tumor DNA (ctDNA), are increasingly being explored. The integration of bioinformatics, omics analysis, and high-throughput technologies with qPCR is accelerating biomarker discovery. Furthermore, large-scale parallel sequencing is emerging as a potential alternative to relative quantification and microarray techniques. Nevertheless, qPCR remains essential for validating specific biomarkers, and further standardization of its protocols is necessary to enhance reliability. This study provides a systematic analysis of qPCR-based biomarker research and underscores the need for future technological integration and standardization to facilitate broader clinical applications.

References

Bustin S . Improving the quality of quantitative polymerase chain reaction experiments: 15 years of MIQE. Mol Aspects Med. 2024; 96:101249. DOI: 10.1016/j.mam.2024.101249. View

Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D . Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3). PMC: 6988269. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045. View

Chu D, Pan Y, Cheng S, Hui K, Krishnan P, Liu Y . Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 2020; 66(4):549-555. PMC: 7108203. DOI: 10.1093/clinchem/hvaa029. View

Mills M, Juergens K, Gov J, McCormick C, Sampoleo R, Kachikis A . Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays. J Clin Virol. 2023; 159:105373. PMC: 9783225. DOI: 10.1016/j.jcv.2022.105373. View

Huggett J, OSullivan D, Cowen S, Cleveland M, Davies K, Harris K . Ensuring accuracy in the development and application of nucleic acid amplification tests (NAATs) for infectious disease. Mol Aspects Med. 2024; 97:101275. DOI: 10.1016/j.mam.2024.101275. View

Lin Y, Qian F, Shen L, Chen F, Chen J, Shen B . Computer-aided biomarker discovery for precision medicine: data resources, models and applications. Brief Bioinform. 2017; 20(3):952-975. DOI: 10.1093/bib/bbx158. View

Perumal P, Abdullatif M, Garlant H, Honeyborne I, Lipman M, McHugh T . Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR. Front Immunol. 2021; 11:612564. PMC: 8029985. DOI: 10.3389/fimmu.2020.612564. View

Batis N, Brooks J, Payne K, Sharma N, Nankivell P, Mehanna H . Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation. Adv Drug Deliv Rev. 2021; 176:113854. PMC: 8448142. DOI: 10.1016/j.addr.2021.113854. View

Chen C, Hu Z, Liu S, Tseng H . Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. 2012; 12(5):593-608. DOI: 10.1517/14712598.2012.674507. View

10.

van Eck N, Waltman L . Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010; 84(2):523-538. PMC: 2883932. DOI: 10.1007/s11192-009-0146-3. View

11.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

12.

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

13.

Mitchell P, Parkin R, Kroh E, Fritz B, Wyman S, Pogosova-Agadjanyan E . Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105(30):10513-8. PMC: 2492472. DOI: 10.1073/pnas.0804549105. View

14.

Chen Y, Wang X . miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2019; 48(D1):D127-D131. PMC: 6943051. DOI: 10.1093/nar/gkz757. View

15.

Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

16.

Schwarzenbach H, Nishida N, Calin G, Pantel K . Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014; 11(3):145-56. DOI: 10.1038/nrclinonc.2014.5. View

17.

Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Teilum M . Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2012; 59(1):S1-6. DOI: 10.1016/j.ymeth.2012.09.015. View

18.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

19.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

20.

Boobalan J, Torti A, Dinesha T, Solomon S, Balakrishnan P, Saravanan S . Cost-effective HIV-1 virological monitoring in resource-limited settings using a modified commercially available qPCR RNA assay. J Virol Methods. 2017; 248:71-76. DOI: 10.1016/j.jviromet.2017.05.007. View